Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SWIFT I/II: Sanitation, Water, and Instruction in Face-washing for Trachoma
NCT02754583Phase 3Completed
- Sponsor
- University of California, San Francisco
- Start
- Dec 2015
- Primary completion
- Dec 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of azithromycin in trachoma (5 arms), sponsored by University of California, San Francisco. Primary endpoints: Village-specific ocular chlamydia among 0-5 children over time at 96 months, Ocular chlamydia among 8-12 year olds at 24 months and 2 more. Started Dec 2015; status: completed.
02
Drugs
azithromycin
03
Conditions
trachoma
Beyond the preview
Go deeper on NCT02754583.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02754583.